A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study to evaluate the efficacy and safety of JS005 in 702 adult patients with moderate-to-severe chronic plaque psoriasis
Epistemonikos ID: 1f60fbda5374236908d78a1a7cf10ba92dca78c5
First added on: May 15, 2024